First quality-of-life data of a sequential dose-dense regimen in advanced ovarian cancer: A multicenter phase II study of the Northeastern German Society of Gynecological Oncology.
G. Oskay-Ă–zcelik
No relevant relationships to disclose
R. Richter
No relevant relationships to disclose
K. Pietzner
No relevant relationships to disclose
H. Hindenburg
No relevant relationships to disclose
H. L. Sommer
No relevant relationships to disclose
R. Chekerov
No relevant relationships to disclose
O. Camara
No relevant relationships to disclose
E. Keil
No relevant relationships to disclose
J. Einenkel
No relevant relationships to disclose
W. Lichtenegger
No relevant relationships to disclose
J. Sehouli
No relevant relationships to disclose